YTHDF3 and carcinoma: To further study the relationship between YTHDF3 expression and clinicopathological characteristics of HCC patients, 466 HCC patients were divided into YTHDF3 low-expression (IHC score<8) and high-expression group (IHC score ≥ 8) according to IHC median score of carcinoma tissue.